Pathwork Diagnostics raises $30M in Series C Funding
Pathwork Diagnostics, a Redwood City, California-based molecular diagnostics company, has raised $30 million in Series C financing, it announced. The round was led by Alta Partners, with return investors Abingworth, Advent Venture Partners, Novus Ventures, Prospect Venture Partners and Venrock. Pathwork also announced that David Mack, PhD, a director at Alta Partners, has joined the board of directors.
6 October 2010•3 mins read
